Why Patients Nationwide Choose NeuroSpa Patients Travel Worldwide for Our Unique Treatment Approach Advanced Neurology & Neuropsychiatry in Newport Beach, CA


Neurology · Memory & cognitive health

TMS Treatment for Dementia

Memory changes can raise difficult questions for individuals and their families. Learn about dementia, how neurologists evaluate cognitive symptoms, and emerging research exploring transcranial magnetic stimulation (TMS).

At NeuroSpa Brain Rejuvenation Centers, care begins with a neurological evaluation and a conversation about individual needs and available options.

Neurological evaluationNon-invasive TMSPersonalized approach
Illustrative image of a clinician discussing memory concerns with a patient and family member
Illustrative AI-generated image — not actual NeuroSpa staff or patients.
Start here

What is dementia?

Dementia refers to a group of conditions that cause changes in memory, thinking, language, behavior or everyday functioning. Alzheimer’s disease is one of the most common causes, but dementia can take several different forms.

Normal age-related forgetfulness is not the same as progressive memory loss. When symptoms affect everyday activities, a neurological assessment can help identify possible causes and appropriate next steps.

Dementia is not one single disease. Different causes produce different symptom patterns and may call for different approaches to evaluation and care.

NeuroSpa video — learn about TMS and memory-related concerns.

Preliminary clinical observations

What did NeuroSpa observe after TMS?

These actual clinical findings in real-world clinic patients with dementia and/or mild cognitive impairment (MCI) are very encouraging and in line with other published research trials showing how TMS can benefit patients with dementia.

A blood marker was tracked

We compared the Aβ42/40 ratio, a blood measurement associated with Alzheimer’s pathology, before and after TMS at our clinic.

All six ratios significantly improved after TMS

Patients experienced a significant trend towards reaching normal serum amyloid ratios after TMS treatment.

Cognitive scores Improved

The data showed an average six-point improvement on standardized cognitive exams (MOCA).

6

Patients in the biomarker chartIndividual before-and-after measurements

6 of 6

Ratios increasedAβ42/40 moved upward in the supplied figure

+6

Average cognitive test points reportedStandardized cognitive exam (MOCA)

Data from the clinic flyer

Detailed Alzheimer’s biomarker measurements

All six patients in the clinic flyer had a higher Aβ42/40 blood-test ratio after TMS. The visual summary below makes it easy to compare where each patient started and where they measured after treatment.

At-a-glance Aβ42/40 trend view

Each patient is shown on the same colored scale so families can quickly see the direction of change from before TMS to after TMS.

< 0.150   Higher-likelihood range0.150–0.169   Borderline / intermediate≥ 0.170   Normal / lower-risk range

P1

Before 0.127After 0.161

P2

Before 0.150After 0.176

P3

Before 0.142After 0.183

P4

Before 0.156After 0.168

P5

Before 0.140After 0.157

P6

Before 0.151After 0.161
Blue dot = before TMS Green dot = after TMSAnimated connector = measured change
This overview is designed to make the flyer data easier for patients and families to understand at a glance, while the detailed chart and interpretation table remain below.
Aβ42/40 ratio0.120.140.160.180.1610.127Patient 10.1760.150Patient 20.1830.142Patient 30.1680.156Patient 40.1570.140Patient 50.1610.151Patient 6

Before TMSAfter TMS
6 of 6Every patient shown had a higher ratio after treatment.
+0.023Average increase across the six paired values shown.
P3 +0.041Largest increase among the six displayed measurements.

Patient 1

↑ +0.034

Before 0.127After 0.161

Patient 2

↑ +0.026

Before 0.150After 0.176

Patient 3

↑ +0.041

Before 0.142After 0.183

Patient 4

↑ +0.012

Before 0.156After 0.168

Patient 5

↑ +0.017

Before 0.140After 0.157

Patient 6

↑ +0.010

Before 0.151After 0.161
TMS coil Scalp & skull (non-invasive) Cerebral cortex target region

Magnetic pulses pass through the scalp and skull without surgery or implants. The targeted region is the cerebral cortex.

Understanding care

Evaluation, cognitive testing and follow-up

Memory concerns can have different causes. Assessment may involve a neurological examination, review of medical history, standardized cognitive testing, imaging, and laboratory evaluation when appropriate.

TMS is a non-invasive form of brain stimulation using targeted magnetic pulses. Research is exploring whether it may have a role in certain cognitive conditions. Whether it is appropriate for an individual with dementia requires careful medical evaluation.

Explore a memory test ↗

Recognizing differences

How do different types of dementia differ?

Different disorders may affect memory, language, behavior and movement in different ways. The following overview summarizes important distinctions.

Alzheimer’s disease

Often begins with difficulty learning and recalling recent information. Unlike ordinary forgetfulness, progressive memory loss may persist even when reminders or clues are provided.

Frontotemporal dementia

May first involve changes in social behavior, judgment or inhibitions. Some forms predominantly affect language, word finding or speech.

Vascular dementia

Can follow reduced blood supply or strokes affecting the brain. Changes in thinking may sometimes occur in a stepwise pattern.

Parkinson’s disease dementia

May combine changes in attention and memory with movement symptoms such as slowed walking, tremor, reduced facial expression or speech changes.

For patients and loved ones

Making sense of memory changes together

Living with memory concerns can affect the entire family. Neurological evaluation helps patients and caregivers better understand symptoms, consider appropriate treatment options, and plan the next steps.

Our approach emphasizes clear explanations, individualized assessment and realistic discussions of what current evidence does — and does not — support.

Illustrative image of an older adult reviewing information with a supportive family member
Illustrative AI-generated image — not actual NeuroSpa patients.
Learn and listen

Videos and patient perspectives

Explore NeuroSpa’s videos about dementia, memory disorders, brain stimulation, and related treatment experiences. Play the videos directly on this page.

TMS for Memory Disorders — Patient Testimonial

Discussion of TMS and memory disorders with patient experience.

TMS for Dementia — An Advance in Treatment Options

Dr. Elahi discusses TMS research and clinical approaches for dementia.

Brain Enhancement: Improving Cognitive Function

Dr. Elahi discusses brain stimulation strategies and cognitive function.

Open full video page ↗

Testimonial: Treatment of Memory Disorders with TMS

A patient and caregiver describe their personal experience with treatment. Outcomes vary.

Open full testimonial page ↗

Published clinical literature

Research on TMS and Alzheimer’s disease

Published case report

In a 2023 case report by Elahi and Frechette, a 44-year-old patient with early-onset Alzheimer’s disease showed improvements on several cognitive measures following rTMS.

Reported changes included memory (+22%), executive functioning (+32.4%), attention (+13.2%), verbal functioning (+148%) and working memory (+19%). These percentages describe one patient and cannot predict individual outcomes.

Read the published case report ↗

Where TMS fits in dementia care

Current dementia care may include approved medications, supportive therapies, symptom management, safety planning and caregiver assistance. Some treatments aim to slow aspects of disease progression in eligible patients.

Research into TMS for Alzheimer’s and dementia is ongoing. It is not established as a cure or proven way to reverse Alzheimer’s disease, and the clinic’s biomarker series should be interpreted as preliminary.

Questions about evaluation? Call (949) 652-7301.

Selected references

  1. Bentwich J. et al. (2011). Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease: a proof-of-concept study. Journal of Neural Transmission.
  2. Cotelli M. et al. (2006). Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease. Archives of Neurology.
  3. Cotelli M. et al. (2011). Improved language performance in Alzheimer disease following brain stimulation. Journal of Neurology, Neurosurgery & Psychiatry.
  4. Ahmed M.A. et al. (2012). Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer’s dementia. Journal of Neurology.
  5. Rabey J.M. et al. (2013). Repetitive transcranial magnetic stimulation combined with cognitive training in Alzheimer’s disease: a randomized double-blind study. Journal of Neural Transmission.

These references were retained from the existing Dementia article; full bibliographic details and clinical wording should be reviewed before publication.

Research notice: The six-patient biomarker values and average cognitive-score statement come from a NeuroSpa clinic flyer describing a patient series intended for journal submission. They are distinct from the published 2023 single-patient case report. The findings are not a controlled efficacy demonstration. TMS is investigational for Alzheimer’s disease. Treatment decisions require consultation with a qualified clinician.

Have questions about memory or dementia care?

Talk with NeuroSpa about a neurological evaluation, cognitive testing, and evidence-informed care options for you or a family member.

;